Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zachary S Wallace

Showing results (1-10 of 207) with videos related to

Pageof 21
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab UsersZachary S Wallace, Michael Putman
Rheumatic Diseases Clinics of North America|November 4, 2022
Environmental Triggers for VasculitisGuy Katz, Zachary S Wallace
Frontiers in Immunology|December 24, 2019
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?Zachary S Wallace, John H Stone
Rheumatic Diseases Clinics of North America|June 18, 2023
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019Sebastian E Sattui, Zachary S Wallace
JAMA|December 21, 2021
Therapeutic Drug Monitoring for Immune-Mediated Inflammatory DiseasesZachary S Wallace, Jeffrey A Sparks
Current Opinion in Rheumatology|November 9, 2020
Management of primary vasculitides with biologic and novel small molecule medicationsNaomi Serling-Boyd, Zachary S Wallace
Arthritis Care & Research|May 6, 2024
Patient-Reported Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Are the Answers in Front of Our Noses?Sebastian E Sattui, Zachary S Wallace
Rheumatic Diseases Clinics of North America|November 16, 2024
Lessons Learned from the COVID-19 Pandemic in RheumatologyJeffrey A Sparks, Zachary S Wallace
Current Opinion in Rheumatology|November 22, 2014
An update on IgG4-related diseaseZachary S Wallace, John H Stone
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2024
Mechanisms and Screening for Atherosclerosis in Adults With VasculitisMichael J Hendrickson, Zachary S Wallace
Pageof 21

Showing results (1-10 of 207) with videos related to

Sort By:
Pageof 21
Arthritis & Rheumatology (Hoboken, N.J.)|May 16, 2023
Weighing the Risks and Benefits of Pneumocystis Jirovecii Pneumonia Prophylaxis in Rituximab UsersZachary S Wallace, Michael Putman
Rheumatic Diseases Clinics of North America|November 4, 2022
Environmental Triggers for VasculitisGuy Katz, Zachary S Wallace
Frontiers in Immunology|December 24, 2019
Personalized Medicine in ANCA-Associated Vasculitis ANCA Specificity as the Guide?Zachary S Wallace, John H Stone
Rheumatic Diseases Clinics of North America|June 18, 2023
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019Sebastian E Sattui, Zachary S Wallace
JAMA|December 21, 2021
Therapeutic Drug Monitoring for Immune-Mediated Inflammatory DiseasesZachary S Wallace, Jeffrey A Sparks
Current Opinion in Rheumatology|November 9, 2020
Management of primary vasculitides with biologic and novel small molecule medicationsNaomi Serling-Boyd, Zachary S Wallace
Arthritis Care & Research|May 6, 2024
Patient-Reported Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Are the Answers in Front of Our Noses?Sebastian E Sattui, Zachary S Wallace
Rheumatic Diseases Clinics of North America|November 16, 2024
Lessons Learned from the COVID-19 Pandemic in RheumatologyJeffrey A Sparks, Zachary S Wallace
Current Opinion in Rheumatology|November 22, 2014
An update on IgG4-related diseaseZachary S Wallace, John H Stone
Arteriosclerosis, Thrombosis, and Vascular Biology|November 21, 2024
Mechanisms and Screening for Atherosclerosis in Adults With VasculitisMichael J Hendrickson, Zachary S Wallace
Pageof 21